Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs104886003
rs104886003
A 0.700 CausalMutation CLINVAR Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. 21430269

2011

dbSNP: rs121913273
rs121913273
A 0.700 CausalMutation CLINVAR Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. 21430269

2011

dbSNP: rs121913279
rs121913279
G 0.700 CausalMutation CLINVAR Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. 21430269

2011

dbSNP: rs121913279
rs121913279
T 0.700 CausalMutation CLINVAR Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. 21430269

2011

dbSNP: rs104886003
rs104886003
C 0.700 CausalMutation CLINVAR High frequency of mutations of the PIK3CA gene in human cancers. 15016963

2004

dbSNP: rs104886003
rs104886003
A 0.700 CausalMutation CLINVAR High frequency of mutations of the PIK3CA gene in human cancers. 15016963

2004

dbSNP: rs121913273
rs121913273
A 0.700 CausalMutation CLINVAR High frequency of mutations of the PIK3CA gene in human cancers. 15016963

2004

dbSNP: rs121913279
rs121913279
T 0.700 CausalMutation CLINVAR High frequency of mutations of the PIK3CA gene in human cancers. 15016963

2004

dbSNP: rs121913279
rs121913279
G 0.700 CausalMutation CLINVAR High frequency of mutations of the PIK3CA gene in human cancers. 15016963

2004

dbSNP: rs104886003
rs104886003
A 0.700 CausalMutation CLINVAR Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors. 22162589

2012

dbSNP: rs104886003
rs104886003
C 0.700 CausalMutation CLINVAR Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors. 22162589

2012

dbSNP: rs121913273
rs121913273
A 0.700 CausalMutation CLINVAR Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors. 22162589

2012

dbSNP: rs121913279
rs121913279
G 0.700 CausalMutation CLINVAR Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors. 22162589

2012

dbSNP: rs121913279
rs121913279
T 0.700 CausalMutation CLINVAR Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors. 22162589

2012

dbSNP: rs104886003
rs104886003
A 0.700 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005

dbSNP: rs104886003
rs104886003
C 0.700 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005

dbSNP: rs121913273
rs121913273
A 0.700 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005

dbSNP: rs121913279
rs121913279
T 0.700 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005

dbSNP: rs121913279
rs121913279
G 0.700 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005

dbSNP: rs104886003
rs104886003
C 0.700 CausalMutation CLINVAR PIK3CA mutation status in Japanese lung cancer patients. 16930767

2006

dbSNP: rs104886003
rs104886003
A 0.700 CausalMutation CLINVAR PIK3CA mutation status in Japanese lung cancer patients. 16930767

2006

dbSNP: rs121913273
rs121913273
A 0.700 CausalMutation CLINVAR PIK3CA mutation status in Japanese lung cancer patients. 16930767

2006

dbSNP: rs121913279
rs121913279
T 0.700 CausalMutation CLINVAR PIK3CA mutation status in Japanese lung cancer patients. 16930767

2006

dbSNP: rs121913279
rs121913279
G 0.700 CausalMutation CLINVAR PIK3CA mutation status in Japanese lung cancer patients. 16930767

2006

dbSNP: rs104886003
rs104886003
A 0.700 CausalMutation CLINVAR Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models. 20453058

2010